Redsense Medical AB

Redsense Medical develops and manufactures patented fiber optic blood leak detection systems designed for hemodialysis access monitoring. The company's core offering detects venous needle dislodgement and central catheter leakage through innovative fiber optic sensor technology, triggering immediate alarms to prevent blood loss. The system is available in two configurations: venous fistula and central catheter solutions. Redsense devices are FDA-cleared and CE-marked for use across all dialysis modalities. The alarm unit integrates with IEC PAS 63023-compliant dialysis machines, enabling automatic blood flow stoppage when leakage is detected. The technology addresses a critical patient safety gap in hemodialysis by enabling rapid detection and response to access complications. Redsense operates across Europe and North America with a focus on dialysis provider deployment.